250 likes | 266 Views
Since 1995, there has been a concerning TB incidence in Ukraine. The country faces economic losses, high mortality rates, and unsolved challenges in treatment and diagnosis. From the high TB incidence in cities like Kyiv to the struggle with drug resistance and inefficient testing methods, Ukraine's battle against TB requires urgent attention and systematic improvements. The need for centralized patient registers, effective monitoring, and rational use of resources emerges as key solutions. Thank you for your interest in combating TB in Ukraine.
E N D
TB in Ukraine Vasyl Melnyk
< 10 10-24 25-49 50-99 > 100 Since 1995 TB epidemic in Ukraine
TB incidence in Ukraine, 1992 - 2002 (per 100,000 population)
TB incidence in Ukraine, 2002 (per 100,000 population) Чернигов Сумы Луцк Ровно Житомир КИЕВ Львов Харьков Хмельницький Полтава Луганск Тернополь Черкасы Винница Ивано-Франковск Днепропетровск Донецк Ужгород Кировоград Черновцы Запорожье Николаев Одесса Херсон < 80,0 Симферополь > 80,0 Севастополь
MBT+ patients make 1/3 instead 2/3 Each hour in Ukraine 4 persons fall ill from TB and 1 dies from TB
TB mortality rates in Ukraine, 1992–2002(per 100,000 population)
SPUTUM BACTERIOSCOPY • General medical service on 2045273 SB has spent 8487882,95 grn. (effectiveness of finding 1-2 %) • TB service on 450477 SB has spent 1869479,55 grn. (+ culture examination) • It is spent 10,4 mln. grivnas without results.
CULTURAL EXAMINATIONS • TB service has spent 8705029,55 grn on 972629 cultural testings. On 1 new patient it is spent 268,5 grn. on cultures only. • Results is bad. There is no statistics of resistances. The resistance is not examined to drugs ІІ lines. Testings are not standartized.
Unsolved problems (1): • 1) from 27 administrative territories DOTS is only in 2 (Donetsk obl., Kiev); • 2) registration-forms of account are not adapted to international, therefore there are no many data and they are not comparable; • 3) low efficiency of a smear microscopy, as there are bad laboratories;
Unsolved problems (2): • 4) referens-laboratory does not work; • 5) chaotic screenings tuberculin-test, x-ray and other anti-TB activites; • 6) standart treatment of patients is not ewerywhere applied; • 7) it will not be carried out cohort-analysis;
Unsolved problems (3): • 8) drugs of II lines are uncontrolledly used with unreliable definition of sensitivity to them; • 9) there is no centralized register of patients and monitoring is not adjusted; • 10) selected assignments for TB are irrationally used. • Thank You!